Podcast
The Plus SideZ: A GLP-1 Guide to Metabolic Health
Hosted by Kim Carlos · EN
Looking for real information on GLP-1 medications and weight loss? You’re in the right place.
The Plus SideZ Podcast is your go-to space for science-backed conversations about obesity treatment, weight loss, and living with a chronic metabolic disorder. Hosted by Kim Carlos and Kat Carter, we explore GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound, featuring insights from leading obesity specialists, endocrinologists, and bariatric surgeons. But this podcast is about more than just medication—it’s about navigating the mental, emotional, and physical journey of reclaiming your health.
We combat misinformation with education from top experts, helping you think critically about the latest research, treatment options, and systemic challenges in obesity care. And at the heart of it all are the powerful, vulnerable stories of our brave community members—people sharing their real experiences on GLP-1 medications, breaking stigma, and taking control of their health.
Ranked in the top 1% of podcasts globally, The Plus SideZ Podcast has won three awards in just 18 months, including two Anthem Awards for social impact. Featured on Good Morning America, Bloomberg News, and ABC Nightline on Hulu, we’re at the forefront of the conversation on weight loss, obesity care, and the fight to end weight bias.
Join us and be part of a movement that’s changing the way the world understands obesity, health, and metabolic wellness.
Our Linktree
https://linktr.ee/theplussidez
Want to donate?
PayPal
https://www.paypal.com/donate/?hosted_button_id=ZSEE2DRPHDSZN
GoFundMe
https://gofund.me/82c8138e
Shop The Plus SideZ Merch Store
https://the-plus-sidez-podcast.printify.me/products/1
Website
https://theplussidez.com/
41episodes
Episodes
Newest firstAll episodes
Bonus Episode: FAQ Medicare Bridge Program & GLP-1 Coverage
3d ago00:23:27Tap to summarizeResources for the Community:___________________________________________________________________Linktree Our Favorite ThingsNeed help appealing your GLP-1 dials? www.FindHonestCare.com/KimFind Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________*Both Our Advice and that of our Guest Experts along with their insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you.This is a rapid fire FAQ about the Medicare Bridge Program and coverage of with an obesity Doctor. Dr. Michael Albert an Obesity Medicine Specialist joins the conversation to answer common questions about Medicare coverage and the new Medicare Bridge Program, including:• Who qualifies• How the program works• How to apply• Options if you don't qualifyHe also discusses:• Weight loss with GLP-1s in older adults• Protecting muscle mass and prioritizing protein• Side effects to watch for• What to advocate for with your doctorWhether you're on Medicare, approaching eligibility, or helping a loved one navigate obesity treatment, this episode offers practical advice, patient perspectives, and expert guidance.Follow Dr. Michael AlbertInstagram and TikTok: @michaelalbertmdWebsite: MichaelAlbertMD.com______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail!Use Honest Care to Appeal GLP-1 Denials. Go to HonestCare.com/Kim Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →
How GLP-1s Broke Diet Culture
4d ago01:42:57Tap to summarizeResources for the Community:___________________________________________________________________Linktree Our Favorite ThingsNeed help appealing your GLP-1 dials? www.FindHonestCare.com/KimFind Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________"Both Our Advice and our Guest Expert insights don't replace your own care team. Always talk to a doctor who can review your personal records and labs to make the safest choices for you."How GLP-1s Broke Diet CultureFor decades, we believed weight gain and weight loss were mostly about willpower, calories, and exercise. Today, we’re learning there’s much more happening beneath the surface. The biology that drives hunger, metabolism, weight gain, and long-term health is far more complex than we once understood.In this episode, Dr. Chiadi Ndumele, preventive cardiologist at Johns Hopkins Medicine and a leader with the American Heart Association, explains why GLP-1 medications work, how weight, metabolism, and chronic disease are connected, and why the first-ever Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guideline represents a major shift in how we understand and treat weight-related disease. You’ll also hear a powerful patient story that shows why this new understanding is giving hope to millions.In this episode:Why GLP-1 medications work when diets often don’t.What really drives weight gain, weight loss, and long-term weight management.How metabolism, hormones, genetics, and overall health work together.Why understanding your body can help you advocate for the quality care you deserve.GuestDr. Chiadi NdumelePreventive Cardiologist, Johns Hopkins MedicineChair, 2026 American Heart Association/American College of Cardiology Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice GuidelineResourcesAmerican Heart Association: New Cardiovascular-Kidney-Metabolic (CKM) Clinical Practice Guidelinehttps://www.heart.org/en/news/2026/06/09/new-ckm-guideline-urges-early-weight-talks-to-prevent-health-risksProfessional Heart Daily: 2026 Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndromehttps://professional.heart.org/en/science-news/2026-guideline-for-the-prevention-detection-evaluation-and-management-of-ckm-syndromeAmerican Heart Association News Release: First-Ever Clinical Practice Guideline for Cardiovascular-Kidney-Metabolic Syndromehttps://newsroom.heart.org/news/first-ever-guideline-on-cardiovascular-kidney-metabolic-syndrome-issued______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail!Use Honest Care to Appeal GLP-1 Denials. Go to HonestCare.com/Kim Honest Care can Appeal GLP-1 Denials. Go to FindHonestCare.com/Kim Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →
Why GLP-1s Work When Diets Don’t | Obesity Doctor Explains
1w ago01:38:42Tap to summarizeResources for the Community:___________________________________________________________________Linktree Our Favorite ThingsNeed help appealing your GLP-1 dials?www.FindHonestCare.com/KimFind Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________While Kim takes time away following the loss of her sister, we're revisiting some of our most impactful conversations from Season 1. Thank you for supporting The Plus SideZ Podcast and this community during this time.Why do GLP-1 medications work when years of dieting and exercise often don't?In this episode, obesity medicine physician Dr. Matea Rentea explains why obesity is more than willpower. Through expert insight and a powerful patient story, we explore the science behind obesity, metabolism, hormones, and why "eat less, move more" often isn't enough.In this episode:• Why diets fail for many people living with obesity• How hormones and metabolism affect weight loss• Why GLP-1 medications work differently• The role of exercise, mental health, and weight stigma• Real patient experiences alongside evidence-based medicineWhether you're new to GLP-1s or have been with us since Season 1, this conversation remains one of our most requested episodes.This episode was originally recorded in Season 1. Medical information reflects what was known at the time of recording. Always talk with your healthcare provider before making medical decisions. Follow Dr. Rentea https://www.renteaclinic.com/ ______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail!Use Honest Care to Appeal GLP-1 Denials. Go to HonestCare.com/Kim Honest Care can Appeal GLP-1 Denials. Go to FindHonestCare.com/Kim Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →
GLP-1s and Addiction?
2w ago01:39:48Tap to summarizeResources for the Community:___________________________________________________________________Linktree Our Favorite ThingsNeed help appealing your GLP-1 dials? www.FindHonestCare.com/KimFind Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Can GLP-1s Affect Food Noise, Alcohol, and Addiction?** While Kim takes time away following the passing of her sister, we're revisiting some of our most impactful conversations. Thank you for your kindness, patience, and continued support of The Plus SideZ Podcast.We're sharing this episode because it's more relevant today than when it first aired. Since then, research has expanded interest in whether GLP-1 medications may affect more than weight loss, including food noise, alcohol cravings, and other compulsive behaviors. While the science continues to evolve, so does the conversation.Licensed therapist and addiction treatment leader Dr. Joy Bracey joins community member Brenda, who shares how Mounjaro changed her relationship with food, alcohol, and smoking. Together, they discuss the brain, behavior, and why this emerging area of research is drawing growing interest.**In this episode:**• Brenda's journey with obesity, binge eating, alcohol, smoking, and Mounjaro• Food noise, binge eating, and emotional eating• GLP-1 medications, dopamine, and the brain• Alcohol cravings and addictive behaviors• Mental health, self-love, and healing• Why researchers are studying GLP-1 medications beyond weight loss*Originally recorded during Season 1. This episode reflects the information available at the time of recording. Research and clinical guidance have continued to evolve. It is intended for education and discussion only and is not medical advice. Always consult your healthcare provider regarding your individual care.*______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →
GLP-1 Medicare Coverage FAQ & Weight Loss Tips From Obesity Doctor
3w ago01:30:38Tap to summarizeResources for the Community:___________________________________________________________________Linktree Our Favorite ThingsNeed help appealing your GLP-1 dials? www.FindHonestCare.com/KimFind Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Will Medicare finally expand access to GLP-1 medications for obesity? How do you qualify? In this episode, Kim and Kat are joined by community co-host Deb Cooperman and DeeDee, a 70-year-old GLP-1 patient, to discuss Medicare coverage, weight loss, maintenance, and life on GLP-1s after 60.Deb shares her experience paying cash for treatment while hoping to qualify for the new Medicare Bridge Program. DeeDee discusses maintaining her weight loss after losing access to medication, moving to compounded treatment, and growing up in a generation shaped by diet culture.Topics include:• GLP-1 medications after 60• Weight loss and maintenance• Medicare coverage and affordability• Diet culture and obesity• Long-term patient tips and lessons learned• Access to obesity treatmentObesity medicine specialist Dr. Michael Albert joins the conversation to answer common questions about Medicare coverage and the new Medicare Bridge Program, including:• Who qualifies• How the program works• How to apply• Options if you don't qualifyHe also discusses:• Weight loss with GLP-1s in older adults• Protecting muscle mass and prioritizing protein• Side effects to watch for• What to advocate for with your doctorWhether you're on Medicare, approaching eligibility, or helping a loved one navigate obesity treatment, this episode offers practical advice, patient perspectives, and expert guidance.Follow Guests Follow Deb https://www.instagram.com/thedebcooperman https://www.instagram.com/thedebcooperman Follow Dee DeeTikTok https://www.tiktok.com/@deesback Dr. Michael AlbertInstagram and TikTok: @michaelalbertmdWebsite: MichaelAlbertMD.com#GLP1 #Medicare #MedicareCoverage #ObesityMedicine #WeightLoss #HealthyAging #Zepbound #Wegovy________________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail!Use Honest Care to Appeal GLP-1 Denials. Go to HonestCare.com/Kim Honest Care can Appeal GLP-1 Denials. Go to FindHonestCare.com/Kim Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →
GLP-1 Stall? Why Your Body Stops Losing Weight | Dr. Michelle Gordon
Jun 1501:04:04Tap to summarizeResources for the Community:___________________________________________________________________Linktree Our Favorite ThingsNeed help appealing your GLP-1 denials? www.FindHonestCare.com/KimRo - Telehealth for GLP1 Weight ManagementGLP-1 Stall? Why Your Body Stops Losing Weight | Dr. Michelle GordonHosts Kim Carlos and Kat Carter talk with obesity medicine specialist Dr. Michelle Gordon about the biological factors behind a GLP-1 weight loss plateau. If you are on a medication like tirzepatide or semaglutide and the scale stops moving, it is driven by a complex neuroendocrine response.Dr. Gordon explains that the hypothalamus operates like a stubborn thermostat, defending a specific weight set point. When you lose weight, the brain reads the change as a threat and triggers physiological defenses. To prevent further weight loss, the body increases hunger hormones and simultaneously lowers its energy expenditure.Key topics include:The Mechanism of a Stall: A weight plateau occurs at the exact point where your declining daily energy expenditure meets your rising natural hunger signals.Menopause and Fat Oxidation: Midlife hormonal shifts cause fat oxidation to drop, which alters metabolic burn rates and shifts fat storage to the stomach.The Chronic Disease Reality: Clinical data shows that stopping a GLP-1 medication typically results in regaining about two thirds of the lost weight, proving obesity requires continuous management.Muscle Mass Preservation: Rapid weight loss from any method causes muscle loss, making strength training essential to preserve lean muscle and protect long-term functional health.Connect to Dr. Michelle Gordon:Substack: https://drmichellegordon.substack.com/Instagram: https://www.instagram.com/doctormichellegordon/Facebook: https://www.facebook.com/drmichellegordon/Practice Website: https://drmichellegordon.com/LinkedIn: https://www.linkedin.com/in/drmichellegordon/______________________________________________________________________Join this channel to get access to perks: / @theplussidez______________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #ObesityCare #PatientAdvocate #GLP1Community #RealGLP1StoriesSend us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →
Debunking the *LIES* About GLP-1s (Ozempic Myths Overruled by Obesity Doctors)
Jun 901:28:40Tap to summarizeLinktree for Community ResourcesNeed help appealing a GLP-1 Insurance Denial? FindHonestCare.com/KimRo - Telehealth for GLP1 Weight ManagementThe Absolute Lies You’ve Heard About GLP-1s (Ozempic Myths Debunked) [REPLAY]Are you being lied to about Ozempic, Mounjaro, and Wegovy? In this special replay episode, leading obesity medicine specialists break down the biggest GLP-1 myths taking over your feed. We are reposting this crucial conversation because it is more relevant than ever. With GLP-1 price changes and expanding access options through federal programs like the Medicare GLP-1 Bridge, understanding the real science behind these medications is essential for patient advocacy.We are sharing a few favorite replay episodes right now while Kim is away on bereavement leave following the loss of her sister. We want to deeply thank our subscribers for staying engaged and supporting the show during this time.In this episode of The Plus Sidez Podcast, Kat joins Kim to sit down with obesity medicine specialists Dr. Matea Rentea and Dr. Ali Novitzki to help listeners better understand their disease and feel empowered in their healthcare journey.The Myths We Debunk:The Muscle Loss Scare: The data behind weight loss and body composition, explaining why the medication itself is not destroying your lean mass.The Willpower Narrative: Why obesity is a genetic, chronic metabolic disease rooted in brain biology, not a failure of personal willpower.The Shot-Only Illusion: How the medication works alongside your body's natural satiety signals and gut receptors.Obesity Doctor Guidance Shared:Metabolic Protection: A practical discussion on utilizing a 10-minute fitness routine and a 100-gram protein framework to maintain lean mass and support insulin sensitivity.System Navigation: Insights on navigating insurance barriers, managing prior authorizations, and advocating for proper medical care.Mental Resilience: Tools to process unsolicited comments about your weight and protect your peace from societal judgment.Episode Topics:Why We Are Replaying This Episode: Prices, Access, and UpdatesThe Insurance Landscape: Understanding Prior AuthorizationsMeet the Obesity Medicine SpecialistsDeconstructing the GLP-1 Muscle Loss NarrativeStrategies for Protecting Your MetabolismWhat the Scales Do Not Show About Insulin ResistanceNatural Satiety Triggers and Gut ReceptorsRecognizing Obesity as a Biological Chronic DiseaseAddressing Weight Stigma and External CommentarySubscribe to The Plus Sidez Podcast for science-backed episodes breaking down metabolic health, body recomposition, and the truth about weight loss.Search TagsGLP1 lies debunked, Ozempic myths, Mounjaro weight loss journey, Wegovy truth, Zepbound body recomposition, insulin sensitivity hacks, natural GLP1 boosters, treating obesity metabolic disease, plus sidez podcast, dr matea rentea, dr ali novitzki_________________________________________________________________________Join this channel to get access to perks:https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join_________________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovySend us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →
GLP-1 Over 60: Obesity Doctor Explains Part 2
Jun 101:04:31Tap to summarizeLinktree for Community ResourcesNeed help appealing your GLP-1 insurance denials? Try findhonestcare.com/kimRo - Telehealth for GLP1 Weight Management_________________________________________________________________________GLP-1 Over 60: Why This Feels Different Now Part 2***Note: Kim had some sound issues, so we appreciate your patience and grace with her audio this episode. What does it mean to start GLP-1 treatment later in life… after years of trying to make weight loss work?In this episode, Kim and Kat talk with Dr. Lindsey Ogle, an obesity specialist, and Deb Cooperman, an obesity care advocate and content creator, about starting GLP-1 treatment in your 60s and why the experience can feel different this time around.As more adults over 60 explore GLP-1 medications, Deb shares her story openly, from decades of diet culture and early messaging about weight to grief, food noise, and navigating obesity treatment later in life. And we also discuss the upcoming coverage of GLP-1s for obesity on Medicare (and maybe Medicaid) in July 2026. Dr. Ogle helps connect those experiences to the science, including expectations, side effects, protein, muscle preservation, and what support can look like as we age.What we cover:- GLP-1 weight loss over 60- Food noise and obesity beyond willpower- Diet culture and lifelong messaging around weight- Grief, stress, and emotional eating- Protein, muscle preservation, and aging on GLP-1s- Side effects and realistic expectationsFollow Deb Follow Dr. Ogle _________________________________________________________________________Join this channel to get access to perks:https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join_________________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovySend us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →
GLP-1 Over 60: Why This Feels Different Now Part 1
May 2801:01:21Tap to summarizeLinktree for Community ResourcesNeed help appealing your GLP-1 insurance denials? Try findhonestcare.com/kimRo - Telehealth for GLP1 Weight Management and GLP-1 _________________________________________________________________________***Note: Kim had some sound issues, so we appreciate your patience and grace with her audio this episode. What does it mean to start GLP-1 treatment later in life… after years of trying to make weight loss work?In this episode, Kim and Kat talk with Dr. Lindsey Ogle, an obesity specialist, and Deb Cooperman, an obesity care advocate and content creator, about starting GLP-1 treatment in your 60s and why the experience can feel different this time around.As more adults over 60 explore GLP-1 medications, Deb shares her story openly, from decades of diet culture and early messaging about weight to grief, food noise, and navigating obesity treatment later in life. And we also discuss the upcoming coverage of GLP-1s for obesity on Medicare (and maybe Medicaid) in July 2026. Dr. Ogle helps connect those experiences to the science, including expectations, side effects, protein, muscle preservation, and what support can look like as we age.What we cover:- GLP-1 weight loss over 60- Food noise and obesity beyond willpower- Diet culture and lifelong messaging around weight- Grief, stress, and emotional eating- Protein, muscle preservation, and aging on GLP-1s- Side effects and realistic expectationsFollow Deb Follow Dr. Ogle _________________________________________________________________________Join this channel to get access to perks:https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join_________________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovySend us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →
GLP-1 & PCOS: Why So Many Women Were Misdiagnosed
May 2301:31:24Tap to summarizeLinktree for Community ResourcesNeed help appealing GLP-1 insurance denials? findhonestcare.com/kimRo - Telehealth for GLP1 Weight ManagementRo.Co/PlusSideZ_________________________________________________________________________What if millions of women with PCOS were misunderstood for years because the condition was treated mainly as a reproductive disorder instead of a metabolic disease tied to insulin resistance, obesity, hormones, and fertility?In this episode of The Plus SideZ Podcast, Dr. Melanie Cree, a pediatric endocrinologist, obesity researcher, and PCOS/PMOS expert, explains the recent global consensus to rename PCOS to PMOS, or Polyendocrine Metabolic Ovarian Syndrome, to better reflect the condition’s metabolic and hormonal impact.Dr. Cree breaks down how delayed diagnosis and outdated understanding may have prevented many patients from getting earlier metabolic treatment and intervention.We discuss:Why so many women with PCOS were misunderstood or dismissedThe connection between PCOS, PMOS, insulin resistance, obesity, and fertilityWhy weight gain is not just about willpowerAdolescent PCOS and why early intervention mattersGLP-1 medications like semaglutide for PCOS/PMOSEmerging research focused on ovulation, fertility, and metabolic healthHow hormones, appetite, and metabolism are connectedWhy the PMOS name change could improve diagnosis and treatmentDr. Cree also shares information about her ongoing research and studies exploring how GLP-1 medications may help improve metabolic and reproductive health in people with PCOS/PMOS.Learn more about studies https://medschool.cuanschutz.edu/pediatrics/sections/endocrinology/endocrinology-research/cree-lab/Cree-Melanie-UCD4665?utm_source=chatgpt.com_________________________________________________________________________Join this channel to get access to perks:https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join_________________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovySend us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
Transcribe →